STOCK TITAN

9,292-share sale planned; HealthEquity (NASDAQ: HQY) insider reported recent 791-share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

HealthEquity insider notice to sell Common Stock. A Form 144 filing lists 9,292 shares of Common Stock scheduled for sale in connection with restricted stock vesting on 03/31/2026. The filing also reports 791 shares were sold on 01/09/2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 records a planned resale tied to compensation vesting and a small recent sale.

The filing shows 9,292 shares associated with restricted stock vesting and scheduled for sale on 03/31/2026, and a reported sale of 791 shares on 01/09/2026. The entry lists the broker address and indicates the issuer as the source of the vested shares.

These items are routine insider liquidity notices; cash‑flow treatment and sale method details are not provided in the excerpt. Subsequent transaction details would appear in follow‑on disclosures if sales occur.

Planned shares to sell 9,292 shares restricted stock vesting on 03/31/2026
Shares sold in past 3 months 791 shares sale dated 01/09/2026
Restricted stock vesting date 03/31/2026 vesting associated with the 9,292 shares
Form 144 regulatory
"Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Vesting financial
"Common Stock | 03/29/2023 | Restricted Stock Vesting | ISSUER"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
ISSUER financial
"Restricted Stock Vesting | ISSUER | | | 9292 | 03/31/2026"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does HealthEquity (HQY) Form 144 say about planned insider sales?

It states a planned sale of 9,292 shares tied to restricted stock vesting on 03/31/2026. The filing lists the shares as compensation‑related and names the broker involved.

How many shares were sold recently by the reporting person in the HQY filing?

The filing reports a sale of 791 shares on 01/09/2026. That sale is shown under "Securities Sold During The Past 3 Months" in the excerpt.

Who is the reporting person named in the Form 144 for HQY?

The excerpt names Stephen Neeleman with an address c/o HealthEquity, Inc. in Draper, UT. The broker listed is Morgan Stanley Smith Barney at the provided address.

Are the shares in the HQY Form 144 from compensation or open‑market holdings?

The excerpt identifies the 9,292 shares as related to Restricted Stock Vesting and labels the source as ISSUER, indicating a compensation vesting event.